In other countries
The same active substances on other registers, the same brand first.
- EpysqliBrazil · Samsung Bioepis br Pharmaceutical ltda.Same brand
- EpysqliCanada · 10 MG / ML · Solution · Samsung Bioepis Co., LTDSame brand
- Epysqli 300 MG Concentrado Para Solucion Para PerfusionSpain · 300 mg · concentrado para solución para perfusión · Samsung Bioepis Nl B.V.Same brand
- EpysqliEuropean Union · Samsung Bioepis NL B.V.Same brand
- EpysqliItaly · Concentrato per soluzione per infusione · Samsung Bioepis NL B.V.Same brand
- Epysqli 300 mg concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Samsung Bioepis NL B.V.Same brand
- EpysqliUnited States · 300 mg/30 mL · injection · Samsung Bioepis Co LTDSame brand
- BekemvBrazil · Amgen Biotecnologia do Brasil Ltda.Same form
- HerculizBrazil · Bionovis S.A. - Companhia Brasileira de Biotecnologia FarmaceuticaSame form
- BekemvEuropean Union · Amgen Technology (Ireland) UCSame form
- SolirisEuropean Union · Alexion Europe SASSame form
- SolirisCanada · 10 MG / ML · Solution · Alexion Pharma GMBHSame substance
- BekemvCanada · 10 MG / ML · Solution · Amgen Canada INCSame substance
- Bekemv 300 MG Concentrado Para Solucion Para PerfusionSpain · 300 mg · concentrado para solución para perfusión · Amgen Europe B.V.Same substance
- SOLIRIS 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSIONSpain · 300 mg · concentrado para solución para perfusión · Alexion Europe SasSame substance
- BekemvItaly · Concentrato per soluzione per infusione · Amgen Europe B.V.Same substance
- SolirisItaly · Concentrato per soluzione per infusione · Alexion Europe S.A.S.Same substance
- BEKEMV 300 mg concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Amgen Europe B.V.Same substance
- Soliris, concentraat voor oplossing voor infusie 10 mg/ml (300 mg/30 ml)Netherlands · Concentraat voor oplossing voor infusie · Alexion Europe SASSame substance
- Soliris®Serbia · 300mg · koncentrat za rastvor za infuziju · PredstavniŠTvo Astrazeneca UK Limited BeogradSame substance
- Soliris®Serbia · 300mg · koncentrat za rastvor za infuziju · PredstavniŠTvo Astrazeneca UK Limited BeogradSame substance
- Soliris Concentrate for Solution for Infusion 300mg/vialSingapore · 300 mg / vial · infusion, solution concentrate · Astrazeneca Singapore Pte LTDSame substance
- BkemvUnited States · 300MG/30ML · injectable · Amgen INCSame substance
- SolirisUnited States · 300MG · injectable · Alexion PharmSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Eculizumab
- Register
- Croatia (HALMED)
- Status
- Authorised
- Registration
- 16939
- ATC code
- L04AJ01
- Procedure
- EU centralised
- Supply
- na recept; u ljekarni



